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 Review Article 
Solid dispersion- strategy to enhance solubility and dissolution of a poorly water soluble 
drug 
 
ABSTRACT 
 
Improving oral bioavailability of drugs those given as solid dosage forms remains a challenge for 
the formulation scientists due to solubility problems. Overthe years a variety of solubilization 
techniques have been studied and widely used, as maximum drugs are poorly water soluble in 
pharmaceutical field.  The enhancement of dissolution rate and oral bioavailability is one of the 
greatest challenges in the development of poorly water soluble drugs. Solid dispersions have 
attracted many researchers as an efficient means of improving the dissolution rate and hence the 
bioavailability of a range of poorly water-soluble drugs. The term solid dispersion refers to a 
group of solid products consisting of at least two different components, generally a hydrophilic 
inert carrier or matrix and a hydrophobic drug. Solid dispersion can form either a eutectic 
mixture or solid solution or glass solution or amorphous precipitation in a crystalline carrier or 
compound or complex formation.   
The focus of this review article is on the advantages, limitations,various methods of preparation 
and characterization of the solid dispersion.  
Keywords: Solid dispersion, bioavailability, solubility, solubilization techniques, eutectic 
mixture. 
 
 
INRODUCTION 
Oral drug delivery is the most popular, simplest and easiest way for drugs administration. When 
a drug is administered orally, it must dissolve in gastric and/or intestinal fluids in order to 
permeate the membranes of the GI tract to reach systemic circulation
1
. Therefore, a drug with 
poor aqueous solubility will typically exhibit dissolution rate limitedabsorption, and a drug with 
poor membrane permeability will typically exhibit permeation rate limited absorption. Maximum 
drugs have poor solubility
2
. 
Hence, pharmaceutical research that focus on improving the oral bioavailability of active agents 
by enhancing solubility and dissolution rate of poorly water-soluble drugs
3
.  
The term solid dispersion refers to a group of solid products consisting of a hydrophilic matrix 
and a hydrophobic drug. The matrix can be amorphous or crystalline innature. Solid dispersion 
need not necessarily exist in the micronized state. A fraction of the drug might molecularly 
disperse in the matrix, thereby forming a solid dispersion
4
. When the solid dispersion comes in 
contact of aqueous media, the carrier dissolves and the drug release as a fine colloidal particle, 
resulting enhanced surface area. This results in higher dissolution rate and bioavailability of 
poorly water soluble drugs
5
. In addition, in solid dispersion a portion of drug dissolves 
immediately to saturate gastro intestinal tract fluid and excess drug precipitates as fine colloidal 
particles or only globules of submicron size. Solid dispersion technologies are particularly 
promising for improving the oral absorption and bioavailability of BCS Class II drugs
6
. 
BCS takes into account three major factor; solubility, intestinal permeability and dissolution rate, 
all of which govern the rate extent of oral drug absorption from solid oral-dosage forms
7
. It 
classifies drugs into four classes as shown in table 1. 
 
  
 BCS Classification of drugs. 
S. no. Class Solubility Permeability 
1 Class 1 High Solubility High Permeability 
2 Class 2 Low Solubility High Permeability 
3 Class 3 High Solubility Low Permeability 
4 Class 4 Low Solubility Low Permeability 
 
ADVANTAGES
8, 9, 10
  
1] Enhance solubility and bioavailability of poorly water soluble drugs. 
2] Easy to produce. 
3] Rapid dissolution rate, leads to increase in extent and rate of drug absorption. 
4] Transformation of liquid or gaseous form of drug in tosolid form is possible. 
5] Avoiding polymorphic changes and the consequent bioavailability problems 
6] Easy to prepare rapid disintegration oral tablets by solid dispersion. 
7] Improve porosity of drug. 
DISADVANTAGES
11, 12, 13 
The disadvantages of solid dispersion are enlisted below: 
1] Poor scale-up for the purpose of manufacturing. 
2] Polymers used in solid dispersion can absorbmoisture and cause phase-separation, crystal 
growth and convert amorphous form into crystalline form. It may leads to decrease solubility and 
dissolution rate. 
3] Difficulty in pulverization and sifting because of their tacky and soft nature. 
4] It causes reproducibility of physicochemical characteristics. 
5] Poor stability of dosage form. 
6] Laborious and expensive method of preparation. 
7] Aggregation, agglomeration and air adsorption during formulation. 
8] Decrease in dissolution rate with aging ford. 
Types of solid dispersion 
1. Eutectic mixtures 
Eutectic mixture consists of two compounds which are completely miscible in the liquid state but 
only to a very limited extent in the solid state. These systems are usually prepared by melt fusion 
method. When the eutectic mixture is exposed to water, the soluble carrier dissolves leaving the 
drug in a microcrystalline state which gets solubilized rapidly. Theincrease in surface area is 
mainly responsible for increased rate of dissolution
14
. Examples of this type include phenacetin- 
phenobarbital, Chloramphenicol-urea, griseofulvin-succinic acid, and paracetamol-urea. 
 
 
 
  
Figure 1: Hypothetical phase diagram of eutectic mixture 
 
2. Solid solution 
These consist of a solid solute dissolved in a solid solvent. The particle size of the drug in the 
solid solution is reduced to its molecular size. Solid solutions arecomparable to liquid solutions, 
consisting of just one phase irrespective of the number of components. These systems are 
generally prepared by solvent evaporation or co-precipitation method, in which solute and carrier 
are dissolved in a common volatile solvent such as alcohol
15
. 
Solid solution differs from eutectic mixture in a way that the drug is precipitated out in an 
amorphous form in solid dispersion/solution while it is in crystalline form in eutectics. 
Solid solution can generally be classified according to the extent of miscibility between the two 
components or the crystalline structure of the solid solution as- 
i) Continuous Solid Solutions:  
In this system, the two components are miscible or soluble at solid state in all proportions. Although 
it is theoretically possible but no established solid solution of this kind has been shown to exhibit 
faster dissolution properties. The presence of a small amount of the solublecarrier in the crystalline 
lattice of the poorly soluble drugs may also produce a dissolution rate faster than the pure compound 
with similar particle size16. 
 
 
 Figure 2: Hypothetical Phase Diagram of Continuous Solid Solution  
ii) Substitutional solid solution:  
In substitutional solid solution, the solute molecule substitutes for the solvent molecules in the 
crystal lattice of the solid solvent. It can form a continuous or discontinuoussolid solution. The 
size of the solute and the solvent molecule should be as close as possible
17
. 
 
Figure 3: Substitutional Solid Solution 
iii) Discontinuous Solid Solution 
In contrast to the continuous solid solution, this system has only a limited solubility of a solute in a 
solid solvent. Each component is capable of dissolving the othercomponent to a certain degree above 
the eutectic temperature18.  
 
Figure 4: Hypothetical phase diagram of discontinuous solid solution 
 
iv) Interstitial Solid Solution:  
The solute (guest) molecule occupies the interstitial space of the solvent (host) lattice (Fig. 2.5). 
It usually forms only a discontinuous (limited) solid solution. The size of the solute is critical in 
order to fit into the interstices. It was found that the apparent diameter of the solute molecules 
should be less than that of the solvent in order to obtain an extensive interstitialsolid solution of 
metals
19
. 
  
Figure 5: Interstitial Solid Solution 
3) Glass solution:  
It is a homogenous system in which a glassy or a vitreous carrier solubilized drug molecules in 
its matrix. By an abrupt quenching of the melt, the glassy or vitreous state is usually obtained. It 
is characterized by transparency and brittleness below the glasstransition temperature. On 
heating, it softens progressively without a sharp melting point
20
.  
4) Compound or complex formation:  
This system is characterized by complexation of two components in a binary system during solid 
dispersion preparation. Rate of dissolution and gastrointestinal absorption can be increased by 
the formation of a soluble complex with low association constant
21
.  
Classification of carriers
 
Carriers Examples 
Polymers polyvinylalchol, polyvinylpolypyrrolidone, 
polypyrrolidone, polyethylene glycols, 
hydroxypropylcellulose, 
hydroxypropylmethylcellulose, 
Surfactants Tweens, spans, polyoxyethylene stearates, poly 
(caprolactone)-b-poly (ethylene 
oxide 
Carbohydrates Lactose,sorbitol,mannitol,glucose,maltose,soluble 
starch,cyclylodextrins 
,galactose,xylitol,galactomannan 
Polyglycolized 
glycerides acids 
Gelucire44/14, gelucire 50/13, gelucire62/05 
Cyclodextrins Beta-cyclodextrins, hydroxypropyl-beta-
cyclodextrins 
Dendrimers Citric acid, succinic acid, phosphoric acid, 
starburst, polyamidoamine 
 
Superdisintegrants Sodium starch glycolate, croscarmellose sodium, 
cross-linked polyvinyl 
pyrrolidone, cross-linked algin, gellen gum, 
xanthan gum, calcium silicate etc 
 
Hydrotropes Sodium acetate, sodium citrate, sodium-o-
hydroxyl benzoate, sodium-phydroxyl 
benzoate 
 
 
PREPARATION OF SOLID DISPERSIONS 
1. Fusion method 
First solid dispersions created for pharmaceutical application were prepared by the fusion 
method. It is also referred as the melt method only when the starting materials are in crystalline 
state. Drug and carrier mixture of eutectic composition ismolten at temperature above its eutectic 
temperature. Then molten mass is solidified on an ice bath and pulverized to a powder. The 
solidification is often performed on stainless steel plates to facilitate rapid heat loss. A 
modification of the process involves spray congealing from a modified spray drier onto cold 
metal surfaces
22
. 
2. Freeze-drying method: This method consists of dissolving the drug and carrier in a common 
solvent, which is immersed in liquid nitrogen until it is fully frozen. Then, the frozen solution is 
further lyophilized. An important advantage of freeze drying is that the drug is subjected to minimal 
thermal stress during the formation of the solid dispersion. Furthermore the risk of phase separation 
is minimized as soon as the solution is vitrified23.  
3. Spray-drying:  
This method consists of dissolving or suspending the drug and carrier,then spraying it into a stream 
of heated air flow to remove the solvent. Due to the large specific surface area offered by the 
droplets, the solvent rapidly evaporates and the solid dispersion is formed within seconds, which may 
be fast enough to prevent phase separation24.  
4. Dropping method:  
It is a new procedure for producing round particles from melted solid dispersions. This method does 
not use organic solvents and, therefore, has none of the problems associated with solvent 
evaporation. A solid dispersion of a melted drug carrier mixture is pipetted and then dropped onto a 
plate, where it solidifies into round particles. The size and shape of the particles can be influenced by 
factors such as the viscosity of the melt and the size of the pipette. Thismethod also avoids the 
pulverization and compressibility difficulties25. 
5. Solvent evaporation method: The solvent evaporation method consists of the solubilization of 
the drug and carrier in a volatile solvent that is later evaporated such as ethanol, chloroform, mixture 
of ethanol and dichloromethane. The solvent evaporation process uses organic solvents, the agent to 
intimately mix the drug and carrier molecules. Vacuum evaporation may be used for solvent removal 
at low temperature and also at a controlled rate. More rapid removal of the solvent may be 
accomplished by freeze-drying. The difficulties in selecting a common solvent to both drug and 
carrier may be overcome by using an azeotropic mixture of solvent in water26. 
 
Figure 6: Solvent evaporation method 
 
 6. Supercritical fluid methods: 
 In this method carbon dioxide is used as an anti-solvent for the solute but as a solvent with 
respect to the organic solvent. In these technique drug and carrier are dissolved in a common 
solvent leads to particle formation vessel through a nozzle using carbon-dioxide
27
. 
In addition the ability of carbon dioxide to plasticize and swell polymers can also be exploited 
and the process can be carried out near room temperature. Moreover,supercritical fluids are used 
to lower the temperature of melt dispersion process by reducing the melting temperature of 
dispersed active agent. The temperature condition used in this process is fairly mild (35-75°C), 
which allows handling of heat sensitive biomolecules, such as enzymes and proteins.The use of 
this method reduces residual solvent content, particle size without any degradation
28
. 
7. Co-precipitation method:  
In this method non-solvent is added drop wise to the drug and carrier solution, under constant 
stirring. In the course of the non-solvent addition, the drug and carrier are co-precipitated to form 
micro particles. At the end, the resulted micro particle suspension isfiltered and dried
29
.  
8. Hot melt extrusion method: In this method extruder is utilized for intense mixing of 
components. The components of the extruder are barrel, hopper, a kneading screw, heating 
jacket, and a die. Physical mixture of both the carrier and drug is introduced into the hopper then 
passed through screw and finally it is extruded from the die. The product produced by this 
method can easily be handled because any shape can be adopted
30
. 
CHARACTERIZATION OF SOLID DISPERSION: 
1. Microscopic Methods: 
These methods are used to determine size and observe morphology of solid dispersion. In 
scanning electron microscopy sample coated by gold or palladium -usingvacuum evaporator  
examined at accelerating voltage with suitable magnification
31
. 
2. Spectroscopic methods. 
a. FTIR spectroscopy 
This is used to check interaction between drug and carrier used in formulation of solid 
dispersion. Appearance and disappearance of peak indicate interaction between two compound 
and degradation of drug
32
. 
b. UV visible Spectroscopy 
Spectra of pure drug and dispersed drug are scanned. Calculation of molar extinction provides 
evidence of any decomposition
33
. 
c. X-ray diffraction spectroscopy: 
This is used to study quantitatively the concentration of crystalline compound in mixture. It is 
efficient tool in studying physical nature of solid dispersion. Intensity of X-ray diffraction (or 
reflected) from sample is measured as function of diffractionangle. Compound or complex 
formation can be detected by change in spectra of pure drug
34
.  
3. Thermal Methods 
These methods include exposure of sample to different temperature condition. Studying 
physicochemical interaction between drug and carrier is based on principle of change in thermal 
energy as function of temperature
35
. 
a. Thaw Melting Method 
In this method samples are frozen heated and  suddenlyconverted from solid state  to liquid state. 
Thaw point and melting point can be noted. Limitations of this method is that it depends upon 
subjective observation, therefore not highly reproducible
36
.  
b. Cooling curve Methods 
 In this method prepared physical mixtures are heated and homogeneous melt temperature of each 
mixture is noted. Limitations of this method include time consuming process, it requires 
relatively large amount of sample and not suitable for heat sensitive material
37
. 
c. Differential Thermal Analysis (DTA): 
In this study the temperature difference that develops between a sample and an inert reference 
material is measured, at identical heat treatments. Phase transitions or chemicalreactions can be 
followed by absorption or evolution of heat
38
. 
d. Differential Scanning Calorimetry (DSC) 
This technique it is used to observe fusion and crystallization events, glass transition 
temperatures, oxidation, as well as other chemical reactions
39
.  
4. Dissolution Studies 
Carried out at physiological temperature by using type II USP dissolution apparatus. Dissolution 
profile of solid dispersion or compressed tablet made from solid dispersion is determined by 
comparison between dissolution profile of pure drug, physical mixture and solid dispersion gives 
idea about dissolution rate. Effect of different carrier and their differentproportion on dissolution 
rate of solid dispersion is main characterization tool
40
. 
APPLICATIONS OF SOLID DISPERSIONS:  
Solid dispersion technique has following applications
41, 42, 43, 44
 
1. To formulate sustained release regimen of soluble drugs by using poorly soluble or 
insoluble carriers. 
2. To obtain a homogeneous distribution of a small amount of drug in solid state.  
3. To stabilize unstable drugs against hydrolysis, oxidation,recrimination, isomerisation, 
photo oxidation and other decomposition procedures.  
4. To reduce side effect of certain drugs. 
5. Masking of unpleasant taste and smell of drugs.  
6. Improvement of drug release from ointment, creams and gels.  
 
7. To reduce pre systemic inactivation of drugs like morphine and progesterone. 
Polymorphs in a given system can be converted into isomorphism, solid solution, eutectic 
or molecular compounds. 
8. To formulate a fast release primary dose in a sustained released dosage form. 
9. To dispense liquid or gaseous compounds in a solid dosage.  
10. To formulate a fast release primary dose in a sustained released dosage form.  
 
CONCLUSION 
Solubility plays an important role for a drug formulation and its therapeutic efficacy. Hence, 
enhancing of solubility and bioavailability is the major challenge for the researchers. Solid dispersion 
technique is one of the major techniques to enhance the solubility of drug. It is a promising technique 
for the enhancement of bioavailability of poorly aqueous soluble drugs.It aims at improving the 
dissolution and absorption of drugs by various methods like fusion, solvent evaporation, freeze 
drying etc.  A major focus on the future will become the identification of new surface active carriers 
and self emulsifying carriers for solid dispersion. So, the commercial development of this technique 
is necessary. For it further research is necessary for the better implementation of solid dispersion 
technology on industrial scale. 
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